Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Safety Study on Pregnancy Outcomes in Women Immunized With Seasonal Cell Culture Influenza Trivalent (TIVc) or Quadrivalent (QIVc) Vaccine During Pregnancy

NCT03438487 is registered in ClinicalTrials.gov with Seqirus as lead sponsor.

NCT NCT03438487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03438487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Safety Study on Pregnancy Outcomes in Women Immunized With Seasonal Cell Culture Influenza Trivalent (TIVc) or Quadrivalent (QIVc) Vaccine During Pregnancy
Lead sponsor
Seqirus
Phase
Observational
Overall status
Completed
Start date
September 1, 2017
Completion date
December 31, 2020
Enrollment
692 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

birth defect, influenza, human, pregnancy